InvestorsHub Logo
Followers 1
Posts 131
Boards Moderated 0
Alias Born 09/12/2017

Re: None

Friday, 07/06/2018 9:50:03 AM

Friday, July 06, 2018 9:50:03 AM

Post# of 788
Inducement grants of 200,000 shares to 9 people 90 days ahead of October 5 PDUFA date with a price of $6.95 vesting over 4 years (for 8 of the people). Looks like they could be ramping up sales force?

Duvelisib has Fast Track status for patients with CLL or peripheral T-cell lymphoma (PTCL) who have received at least one prior line of therapy and for FL patients who have received at least two prior therapies. It also has Orphan Drug status in the U.S. and Europe for CLL, SLL and FL.

Things seem to be progressing nicely.

https://finance.yahoo.com/news/verastem-oncology-announces-inducement-grants-200500900.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VSTM News